Emi Kurimoto

Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults

Mitsugi Okawara, Hiroshi Katsuki, Emi Kurimoto et al. · Biochemical Pharmacology · 2006 · 202 citations

Life Sciences, Neurobiology, Neuroscience +16

Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF‐mediated signaling

Hiroshi Katsuki, Emi Kurimoto, Sachiko Takemori et al. · Journal of Neurochemistry · 2009 · 86 citations

Life Sciences, Neurobiology, Neuroscience +17

TAK-071, a novel M1 positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects

Yuu Sako, Emi Kurimoto, Takao Mandai et al. · Neuropsychopharmacology · 2018 · 55 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

FTBMT, a Novel and Selective GPR52 Agonist, Demonstrates Antipsychotic-Like and Procognitive Effects in Rodents, Revealing a Potential Therapeutic Agent for Schizophrenia

Keiji Nishiyama, Hirobumi Suzuki, Toshiya Harasawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 37 citations

Medicine, Neuroscience, Pharmacology +14

An Approach to Discovering Novel Muscarinic M1 Receptor Positive Allosteric Modulators with Potent Cognitive Improvement and Minimized Gastrointestinal Dysfunction

Emi Kurimoto, Satoru Matsuda, Yūji Shimizu et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 30 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15